The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism: Pooled Analysis of 8 Case-control Studies Including 2310 Cases and 3204 Controls
Abstract
Summary: Factor V Leiden and factor II G20210A mutations are two frequent genetic risk factors involved in venous thromboembolism (VTE). The goal of this pooled analysis of 8 case-control studies, comprising a total of 2310 cases and 3204 controls, was to precisely estimate the risk of VTE in patients bearing both mutations (double heterozygotes). Odds ratios for VTE were 4.9 (95% CI; 4.1-5.9) for the factor V Leiden and 3.8 (3.0-4.9) for the factor II G20210A mutation. Fifty-one cases (2.2%) and none of the controls were double heterozygotes. The odds ratio for venous thrombosis in double heterozygotes was 20.0 (11.1-36.1). Twelve percent of patients heterozygous for factor V Leiden were also heterozygous for factor II G20210A and conversely 23% of patients heterozygous for factor II G20210A were also heterozygous for factor V Leiden. Furthermore, in this large population we analyzed the effect of oral contraceptive (OC) in women carrying one of these mutations. Odds ratio for VTE associated with OC was 2.29 (1.72-3.04). In factor V Leiden carriers using OC, the odds ratio for VTE was 10.25 (5.69-18.45). The odds ratio of the association of factor II mutation and OC use was 7.14 (3.39-15.04). Finally, we also confirmed that the frequency of factor V Leiden was lower in patients with pulmonary embolism than in patients with deep vein thrombosis without PE (odds ratio 0.69). Conversely, factor II G20210A mutation was equally balanced in both patient groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandenbroucke, J. P., Koster, T., Rosendaal, F. R., Briët, E., Reitsma, P. H., & Bertina, R. M. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90286-0 · Cited by 1,063
Self-citation
Cited by
Population Screening in the Age of Genomic Medicine
Khoury, M. J., McCabe, L. L., & McCabe, E. R. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmra013182 · Cited by 456
Advances in understanding pathogenic mechanisms of thrombophilic disorders
Dahlbäck, B. (2008) · Blood · doi:10.1182/blood-2008-01-077909 · Cited by 345
ROSENDAAL, F. R., & REITSMA, P. H. (2009) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2009.03394.x · Cited by 291
Self-citationvan Vlijmen, E. F. W., Wiewel‐Verschueren, S., Monster, T. B. M., & Meijer, K. (2016) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13349 · Cited by 136
Metadata
- Authors
- Rosendaal, F., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Hillarp, A., Reny, J.-L., Emmerich, J., & the study group for pooled-analysis in venous thromboembolism
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 2001
- Volume
- 86
- Issue
- 09
- Pages
- 809-816
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W4322703218
- Cited by
- 238
- References
- 1
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism: Pooled Analysis of 8 Case-control Studies Including 2310 Cases and 3204 Controls. https://app.cochat.ai/papers/10.1055/s-0037-1616136
- The paper
- Rosendaal, F., Cattaneo, M., Margaglione, M., De Stefano, V., Cumming, T., Arruda, V., Hillarp, A., Reny, J.-L., Emmerich, J., & the study group for pooled-analysis in venous thromboembolism. (2001). Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous Thromboembolism: Pooled Analysis of 8 Case-control Studies Including 2310 Cases and 3204 Controls. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0037-1616136
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.